Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5221_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
21 Мб
Скачать
 Infectious Disease and Neurocognition
Deshayes et al. (2016), accurate diagnosis requires the following four ndings: (1) blood and/ or CSF eosinophilia; (2) hypodense lesions on brain computed tomog­raphy, and/ or hyperintense lesions on T2- weighted brain or spine magnetic res­onance imaging; (3) high titer of anti- To x oc a ra antibodies in blood and CSF; and (4) above all, clinical and/ or radiological improvement aer anthelmintic treatment. Such investigations require specialist knowledge and equipment, both of which are less likely to be available in the Global South.
Numbers of cases of cerebral toxocariasis in the published literature
Evidence for cerebral toxocariasis in humans has always been dicult to assess, espe­cially at the population level. Most information is gained from case reports in the pub­lished literature. In 1997, Magnaval et al. reviewed the literature published in English from the early 1950s to 1997 and found only 12 published cases of neurological toxo­cariasis as determined by nding Tox o c ar a larvae in the CSF or in the brain and/ or by immunodiagnosis of the CSF. In contrast, Fan et al. (2015) and Deshayes et al. (2016) retrieved 86 and 100 reports, respectively, indicating how greater awareness of the con­dition and improved diagnosis are yielding an increasing number of such reports.
Association between toxocariasis and neurocognitive function
Evidence from humans
As early as 1997, Magnaval and colleagues sought to characterize a recognizable cerebral or neurological syndrome among Tox o ca r a seropositive French adults (Magnaval et al., 1997). Utilizing a case– control study design, the authors compared seropositive cases, with neurological symptoms in the absence of an etiological di­agnosis, with controls matched by age, sex, ethnicity, and travel history outside the European community. e authors did not nd evidence for a recognizable neu­rological syndrome, but the relatively small number of subjects (27) should be noted.
Two early American studies focused upon the relationship between To x oc a ra seropositivity and neuropsychological parameters in young children. Worley et al. (1984) failed to demonstrate a relationship between To x oc a ra seropositivity (at 5.4 percent) and cognitive abnormalities, but aer controlling for social class in 333 children aged 5– 7 years, Marmor et al. (1987) suggested a role for toxocariasis in subtle eects on cognition. Sera were obtained from 4652 children aged 1– 15 years as part of the New York City Department of Health Lead Screening Program. Seropositivity was relatively high at 23.1 percent. A total of 155 cases were matched with controls by age, sex, lead category, and time of sampling. Aer adjustment for
Toxocara 249
ethnicity, socioeconomic status, and current lead status, seropositive children per­formed less well on several measures of neuropsychological tests.
In a detailed prospective study of preschool children deemed to be disadvantaged, seropositivity was assessed when children were aged 2, 3, and 4 years, 10 months (Nelson et al., 1996). Seropositivity rose with age from 2 percent to 14.5 percent. Initial results found a link between To xo c ar a seropositivity and lower initial intel­ligence and less advantageous child rearing, but, aer controlling for confounding variables, statistical signicance was not achieved. However, the authors highlighted the possibility of partial reverse causality, that is, whether the eects were due to the exposure itself or to the initial pre- exposure lower intelligence. Furthermore, the failure to reach statistical signicance may have been inuenced by a sample size that was too small for the detection of what may be small dierences between sero­positive and seronegative groups.
In a signicant departure in terms of scale, several investigators have taken advan­tage of the National Health and Nutrition Examination Survey (NHANES), which is a nationally representative cross- sectional survey of over 33,000 people designed to collect health statistics from a large sample of people representative of the civilian, non- institutionalized general population in the United States. e third such survey took place between 1988 and 1994, and serum samples were analyzed for the pres­ence of Tox o ca ra antibodies.
In the rst contribution to utilize the NHANES data set, Walsh and Haseeb (2012) measured the Wechsler Intelligence Scale for Children— Revised (WISC- R) and the Wide Range Achievement Test— Revised (WRAT- R) in children aged 6– 16 years. Children seropositive for To xo c ar a (n = 688) had signicantly lower scores for both the WISC- R and the WRAT- R compared with seronegative children (n = 3261) aer controlling for important potentially confounding variables such as socioeconomic status, sex, ethnicity, residence, cytomegalovirus, and blood lead levels. e overall seroprevalence for this group was 13.4 percent.
ese ndings were later extended to both young and middle- aged adults (Erickson et al., 2015) and older adults (Erickson et al., 2022), studies that also util­ized the invaluable NHANES database. Erickson et al. (2015) utilized three meas­ures of computer- administered tests of cognitive function in 4279 adults aged 21– 59 years: simple reaction time, symbol– digit substitution, and serial digit learning. e overall seroprevalence for this group of adults was 16 percent, but striking dierences in certain groups were observed. For example, seroprevalence reached 21 percent in non- Hispanic Black, versus 12.8 percent and 13 percent for Hispanic and non- Hispanic White participants, respectively. Furthermore, for those living in poverty, seroprevalence was 22.4 percent, in contrast to 12 percent for those not in poverty. Aer controlling for sex, age, blood lead concentration, educational attainment, ethnic background, and the poverty- to- income ratio, the authors found that toxocariasis predicted worse performance on the symbol– digit substitution test but not on the simple reaction time or the serial digit learning test. Importantly, sero­positivity interacted signicantly with host factors such as sex, age, and educational
 Infectious Disease and Neurocognition
attainment indicating that, for certain groups, the impact of toxocariasis on cogni­tion may be enhanced.
Most recently, Erickson et al. (2022) extended their observations to older adults (aged 60 years and over), utilizing 1350 subjects from the 2013– 2014 NHANES survey. e measures of cognition included assessment of memory function using the word list memory test, executive function by means of verbal uency, and the digit– symbol coding test (evaluation of processing speed). e overall seroprevalence for this group of adults was 8 percent. Tox o c ar a seropositivity was associated with worse performance on both the verbal uency task and on the digit– symbol coding task. Furthermore, To x oc a ra sero- intensity was associated with worse performance on the digit– symbol coding task. Age was found to signicantly inuence the observed re­lationships, but sex, educational achievement, and income did not. No relationship between Tox o c ar a seropositivity and tasks that measured memory were observed.
ese three important studies emphasize the need for the large sample sizes in order to include a sucient number of seropositive cases, the importance of the inclusion of potential confounding variables, and the utilization of a diversity of appropriate tests of cognition. Walsh and Haseeb (2012) have highlighted the cross- sectional design of such studies as an important limitation, as the data cannot be used to draw direct causal conclusions from the associations observed. ese authors also discuss the possibility of reverse causality— that is, that those children who are cognitively disabled may be at greater risk of exposure to To x oc a ra species and hence lead to an increased co­occurrence of toxocariasis and poor cognitive function. Nevertheless, they conclude that the operation of sensitivity analysis precludes the likelihood of reverse causality. Gillespie (1993) suggested that the relationship between To x oc a ra and neurological decits in humans is likely to remain obscure until individual children with mild or asymptomatic disease are studied in some detail, over the course of their infection, in contrast to matched controls. However, for ethical and logistical reasons such a study is unlikely to be undertaken, especially as our understanding of ocular toxocariasis and its potentially devastating sequelae remains obscure. is highlights the myriad of challenges that investigators of such studies face, as mirrored in the literature on cogni­tive development and geohelminth infections (Kvalsvig & Albonico, 2013).
However, to conclude, we do now possess good- quality evidence from large- scale human studies that exposure to Tox o ca r a does have implications for human cogni­tion. Animal models may hold the key to understanding the mechanisms behind the perturbations observed in humans.
Evidence from animal models
Mice as the main species for investigation: Evidence for larval accumulation in the murine brain
As described above, our knowledge of cerebral toxocariasis in humans remains
Toxocara 251
the addition of large psychometric associational studies. A range of animals has been infected with Tox o ca r a (predominantly T. c an is ) under laboratory condi­tions, including mice, rats, guinea pigs, hamsters, gerbils, chickens, quail, pigeons, rabbits, pigs, monkeys, and earthworms (Holland & Hamilton, 2006). Holland and Hamilton (2006) emphasized that for many of these hosts, larval numbers in the brain were either not investigated or no evidence for accumulation was found. However, in contrast, signicant numbers of Tox o ca ra larvae are detected in the mu­rine brain. As early as 1955, Sprent described greater numbers of T. c an is larvae in the murine brain compared to other ascarid species (Sprent, 1955). Burren (1971) explored the location of To xo c ar a larvae in the murine brain and reported higher numbers of larvae in the cerebellum. In an important paper, Dunsmore et al. (1983) infected Canberra C57BL mice with varying doses of To xo c ar a ova and established quantitative evidence for accumulation of T. ca ni s larvae in the brains of mice. Other investigators have described signicant variation in the numbers of larvae detected in the brains of individual outbred mice, indicating the likely role of host heteroge­neity in genetics and immunological response (Cox & Holland, 2001a; Skerrett & Holland, 1997). Mice, therefore, represent useful model systems to explore the im­pact of To x oc a ra on brain biology and behavior and provide possible insights into human cerebral toxocariasis.
Behavioral alterations in T oxocara- infected mice
Although we lack information on behavioral changes in humans exposed to To xo c ar a , there is now considerable evidence to demonstrate that both outbred and inbred laboratory mice infected with To x oc ar a exhibit a range of behavioral alter­ations. A number of key studies have explored the impact of Tox oc ar a infection on murine behaviors, including baseline activity, exploration, response to novelty, anx­iety, learning and memory, and social behavior (Table 16.1). Furthermore, in cases where larval burden has been determined, the magnitude of these alterations can be linked to the numbers of To xo c ar a larvae detected in the murine brain. In one of the earliest studies, Dolinsky et al. (1981) described decreased exploratory be­havior, motor performance, and spatial awareness among infected outbred mice. In an extension of these observations, Burright et al. (1982) infected outbred mice with a range of doses of Tox o ca r a ova and found that mice infected with the highest dose never entered the novel environment compared to mice exposed to the lower doses and control mice. In contrast, and perhaps suggestive that the observations of Burright et al. (1982) may relate to morbidity in the higher- dose group, Hay and Aitken (1984) found that infected mice showed a greater preference for exposed areas and less caution when presented with a novel stimulus. ese mice received an infective dose of 1000 ova. is was the rst of the early studies to assess larval burden in the brain (Table 16.1). However, no statistically signicant correlation was found between the numbers of larvae in the brain and behavioral alterations.
Several studies have provided evidence that T. c an is - infected mice are less active
 Infectious Disease and Neurocognition
Table 16.1 Studies on the relationship between Toxocara infection and behavioral
alterations in mice
Author (year)
Dolinsky et al. (1981)
Burright et al. (1982)
Hay & Aitken (1984)
Hay et al. (1985)
Dolinsky et al. (1985)
Mouse strain Dose Assessment of
Behavioral tests Method larval burden in the brain
Oubred Binghampton
Outbred Binghampton
Strain A 1000 Ye s Motor performance
1000 NA Activity
Response to novelty
250, 500, 1000
NA Exploration
Novel environment
Ambulation &
Home cage Novel cage
Home cage
a
Open eld
Rotating cylinder
Open box Y- maze preference for exposed areas Response to novelty
Strain A 1000 NA Activity (running) Exercise wheel
Outbred Binghampton
1000 Histopathology Activity &
exploration of novel environments Sensorimotor assessments
Home cage
& upper home cage
Open eld Chain
orientation Forelimb grasp Geotaxis response Chain balance test Shock & swim-
temp reactivity
Hay et al.
Inbred STR 1000 NA Activity (short
(1986)
Cox & Holland (1998)
Outbred LACA 100,
1000, 3000,
Ye s Social behavior
250 × 4
Cox & Holland (2001a)
Cox & Holland (2001b)
Outbred LACA Inbred NIH
Outbred LACA
100, 1000, 3000, 250 × 4
100, 1000, 3000,
Ye s Activity Home cage
Ye s Exploration &
250 × 4
Hamilton et al. (2006)
Inbred BALB/ c
2000 Ye s Activity
NIH
Janecek et al. (2017)
Inbred C57BL/
2000 bHistology Activity
6JRccHsd
Notes: a Modied to include two levels. b T. ca ni s and T. ca ti .
bouts)
Anxiety
novelty Learning & memory Anxiety
Learning & memory
Sensorimotor
function Memory
Home cage
Home cage Light/ dark
apparatus & predator odor
“T” maze Water- nding test Elevated plus
maze
Home cage Water- nding test
Home cage Tape removal Maze test/ food
reward
Toxocara 253
2017). However, in contrast, two studies provided evidence for increased activity in To xo c ar a - infected mice (Hay et al., 1985) and hyperactivity as determined by an evaluation of short bouts of activity (Hay et al., 1986). ese studies utilized both outbred and inbred strains of mice (Table 16.1).
Studies using mouse models have also explored the impact of To xo ca r a infec­tion on learning and memory, which is likely to be particularly important for hu­mans. In an important contrast, two studies— one utilizing outbred Laca mice (Cox & Holland, 2001b) and another utilizing two strains of inbred mice (one suscep­tible and one resistant) (Hamilton et al., 2006)— illustrated the signicance of mouse strain selection in studies of this kind. In an earlier study (Cox & Holland, 2001a), Laca mice infected with low, medium, high, and trickle doses of To x oc a ra ova were exposed to a water- nding apparatus as a means of assessing learning and memory. e latency to relocate the water tube, aer a period of deprivation, was taken as an indication of memory impairment. Mice with moderate and high larval numbers in the brain showed a latency to enter the alcove, nd the water tube, and drink from it, although these observations did not attain statistical signicance.
Hamilton et al. (2006) assessed the progression of To x oc ar a infection in seven strains of mice in order to select a susceptible and a resistant strain of mouse to larval establishment in the brain. BALB/ c mice were selected as the susceptible strain, and NIH mice were deemed to be resistant. e choice of strains was supported by previous studies, where BALB/ c mice have been reported to be more susceptible to T. ca ni s infection (Bardón et al., 1994; Epe et al., 1994), and NIH mice demonstrated a higher resistance to T. ca ni s infection than outbred CD1 mice (Abo- Shehada & Herbert, 1989). When the experiments described above were repeated in the inbred BALB/ c and NIH mice using the same protocol, the susceptible BALB/ c mice in­fected with To x oc a ra took statistically signicantly longer to drink from the water bottle than control BALB/ c mice and infected NIH mice, suggesting a degree of memory impairment. Infected BALB/ c mice also took longer to enter the alcove and locate the water bottle in comparison to control mice, but these dierences were not statistically signicant. An alternative explanation for these observations could be lethargy or anorexia induced by To x oc a ra infection. However, activity was also re­corded in these experiments, and infected BALB/ c mice were more ambulatory than their uninfected counterparts and spent less time immobile, suggesting that they were not lethargic (Hamilton et al., 2006). ese contrasting studies emphasize how investigating behavior in inbred strains of mice is attractive as any infection- induced behavioral alterations that could be masked in heterogeneous outbred mice may ap­pear more pronounced (Holland & Hamilton, 2013).
In an important development, Strube and colleagues began to investigate the dif­ferences between T. c an is and T. ca ti in a mouse model. In their rst comparative study, Janecek et al. (2014) infected separate groups of C57Bl/ 6j mice with T. c an is and T. ca ti respectively. Higher numbers of T. ca ni s were detected in the brains of mice compared to T. c at i, mirroring the observations of Havasiovareiterova et al. (1995). Extending their work, Janecek et al. (2017) infected inbred C57BL/ 6JRccHsd
 Infectious Disease and Neurocognition
mice, with separate groups of mice infected with T. c an is and T. ca ti . ey observed reduced exploration and memory impairment in both groups of mice, but in T. ca ti ­infected mice, onset was delayed with less severe progression. Furthermore, T. cati- infected mice displayed reduced fear- related and ight- related reactions rather than motor and neurological disorders (Janecek et al., 2017). ese comparative obser­vations emphasize that despite the evidence that fewer T. cat i migrate to the brain in mice, T. cati can still provoke behavioral changes in an animal model and should not, therefore, be discounted as an etiological agent in cerebral toxocariasis (Janecek et al., 2017; Maciag et al., 2022).
It is possible that the position of the larvae in the brain may inuence the observed behavioral alterations. Previous studies have reported the presence of larvae in the telencephalon (Good et al., 2001) and the cerebellum (Burren, 1971), both areas of the brain being associated with learning and memory and the coordination and con­trol of voluntary movement. However, Janecek et al. (2014) found signicantly more T. c an is larvae in the cerebra of infected mice whereas T. ca ti larvae were mainly lo- cated in the cerebellum.
Overall, the ndings of behavioral alterations in mice associated with To xo c ar a infection suggest the possibility that To xo ca r a infection in humans could be associ­ated with behavioral alterations and even neuropsychiatric diseases, although little research to date has addressed this question. Additional research is warranted to in­vestigate associations between To x oc a ra infection and human behavioral alterations and neuropsychiatric disease.
Cerebral immunity in T oxocara- infected mice and the investigation of biomarkers of brain injury
Our understanding of the cerebral immune response to To x oc a ra is undoubtedly less than that of the systemic immune response (Resende et al., 2015). However, more recently, there has been an increasing focus on the impact of To x oc a ra infec­tion on murine cerebral immunity and biomarkers of brain injury (Table 16.2). As was the case for the behavioral investigations, various parameters— the choice of mouse strain, infective dose, duration of infection and whether larval burden was determined— vary between the studies performed.
Experiments performed in T. c an i s- infected BALB/ c and NIH mice, deemed to be susceptible and resistant, respectively, revealed a mixed response, with generally higher levels of mRNA for interleukin (IL)- 5, IL- 10, interferon gamma (IFN- γ), and inducible nitric oxide synthase (iNOS) in BALB/ c mice compared with NIH mice (Hamilton et al., 2008). Of particular interest was the observation that infected BALB/ c mice displayed signicantly higher levels of all cytokines and iNOS on days 35 and 42 post infection. is signicant upregulation coincided with the behavioral alter­ations observed in infected mice, most notably the impairment of memory (Hamilton et al., 2006, 2008). Furthermore, preliminary data on a small number of mice revealed
Toxocara 255
Table 16.2 Studies on the relationship between Toxocara infection and pathological and immunological parameters in mice
Author (year)
Hamilton et al. (2008)
Liao et al. (2008)
Othman et al. (2010)
Eid et al. (2015)
Mouse strain Dose Assessment
Measures Method of larval burden in the brain
Inbred BALB/ c NIH
2000 Ye s Cytokines:
IL- 5, IL- 10, IFN- γ
Brain injury biomarker:
iNOS
Outbred 250 Ye s Brain injury biomarkers:
GFAP, NF- L, tTG,
AβPP, S100B TGF­β1, tau, UPS, GFAP
Outbred Swiss albino
1000 Ye s Cytokines:
IL- 6, TNF- α
Brain injury biomarkers:
iNOS, GFAP
Neurotransmitters:
GABA, glutamate,
dopamine, norepinephrine, serotonin
Outbred Swiss albino
1000 Ye s Cytokines:
a
IL- 5
Brain injury biomarkers:
GFAP
Semi- quantitative RT- PCR
RT- PCR Western blot & ELISA Immunohistochemistry
Semi- quantitative RT- PCR Immunohistochemistry Reverse- phase HPLC Spectrouorometry
Semi-
quantitative RT- PCR
Immunohistochemistry
Chou et al.
b,c
(2017)
Waindok & Strube
c
(2019)
Waindok et al.
c
(2019)
Outbred ICR
Inbred C57BL/ 6j
Inbred C57BL/ 6j
250,
Ye s Brain injury biomarkers:
500, 1000
TGF- β1, S100B, GFAP,
TG2, claudin- 5, SP, IL- 1β, UPS, Aβ aggregation*
2000 No Cytokines:
G- CSF, GM- CSF, IFN-
γ, IL- 1α, IL- 1β, IL- 2, IL- 3, IL- 4, IL- 5, IL- 6, IL- 7, IL, 8, IL- 9, IL­10, IL- 11, IL- 12(p40), IL- 12(p70), IL- 13, IL- 17A, TNF- α
Chemokines:
CCL11, KC, CXCL1,
MCP- 1, CCL2, MIP­1α, CCL3, MIP- 1β, CCL4, RANTES, CCL5
2000 No Oxylipins:
Prostanoids,
leukotrienes, HETEs,NPD1, 13­HODE, 9- HODE
Western blotting *Modied western
blotting via SDD- AGE
Multiple bead array assay
Liquid chromatography coupled to electrospray ionization tandem mass spectrometry
(continued)
 Infectious Disease and Neurocognition
Table 16.2 Continued
Author (year)
Springer et al. (2019)
Notes: a Both immunocompetent and immunocompromised mice. b Learning and memory assessed by Morris Water Maze. c Both T. ca ni s & T. ca ti . d Same mice as for Janecek et al. (2014).
Abbreviations: ELISA, enzyme- linked immunosorbent assay; HPLC, high- performance liquid chromatography; RT- PCR, reverse transcription polymerase chain reaction; SDD- AGE, semi- denaturating detergent agarose gel electrophoresis.
Mouse strain Dose Assessment
c
Inbred C57BL/
6JRccHsd
2000 No Iba- 1, β- APP,
d
Measures Method of larval burden in the brain
Immunohistochemistry
histopathology
a signicant positive correlation between increased time spent to drink and cytokine levels for both IL- 10 and IFN- γ. Both sets of data were expressed as a percentage in­crease relative to controls for comparability (Holland & Hamilton, 2013).
In contrast to the work of Hamilton and colleagues, Liao and colleagues infected IRC mice with a low dose of To x oc a ra ova (Table 16.2), arguing that the eects of To xo c ar a in the brain in humans are likely to be too cryptic to be clinically detected because the parasite burden is light but that such subtle eects may be deduced from a murine model (Liao et al., 2008). Larval recovery was found to be correspond­ingly low (average of three larvae per brain)— a level similar to that described from low- dose laboratory infections (Cox & Holland, 2001a) and wild rodents (Dubinsky et al., 1995). In a detailed study, each mouse brain was divided into four parts to ob­tain histology and immunohistochemistry, larval recovery, western blotting, and re­verse transcription polymerase chain reaction data. e authors observed increases in several brain injury- associated biomarkers in infected mice including glial bril­lary acidic protein (GFAP), transforming growth factor beta 1, S100B, neurolament light chain, tissue transglutaminases, beta- amyloid precursor proteins, and p- tau. e authors concluded that further work is required to link this observed enhanced expression of brain injury- associated biomarkers with behavioral alterations in ex­perimental cerebral toxocariasis.
In a study that provided novel insights on neurotransmitters, Othman et al. (2010) focused upon proinammatory cytokines and abnormalities in neurotransmitters in a murine model of cerebral toxocariasis. Levels of iNOS and GFAP were also moni­tored. Infected mice demonstrated increased levels of proinammatory cytokines (IL- 6, tumor necrosis factor alpha, and iNOS) as well as signicant disturbances in neurotransmitter proles. Gamma amino butyric acid levels were depressed, exhib­iting a signicant decline over time, whereas levels of glutamate were increased in infected animals. Dopamine and serotonin demonstrated a signicant reduction at 2 weeks post infection. ese changes were most pronounced at the chronic stage of infection. Astrocyte activation as evidenced by enhanced expression of GFAP
Toxocara 257
was also observed in infected animals. is parallels the observations of Liao et al. (2008). Changes in the patterns of neurotransmitters have been linked to a range of complex perturbations in humans, including seizures, behavioral disturbances, and changes in appetite and sleep. ese observations taken together with those on cytokines may explain the behavioral, sleep, and cognitive impairments observed in To xo c ar a - infected humans (Othman et al., 2010). Taking a dierent approach, Eid et al. (2015) infected both immunocompetent and immunosuppressed Swiss albino mice with T. can is (Table 16.2). ese authors observed signicant increases in brain larval counts, reactive gliosis, and a reduction in IL- 5 in the chronic phase of infec­tion in immunosuppressed mice.
In a wide- ranging study that encompassed both behavioral observations and measurement of neurodegeneration, Chou et al. (2017) infected ICR mice with low, medium, and high doses of T. c an is . Of importance was the nding that irrespective of dose, enhanced expression of neurodegeneration- associated factors, persistent ubiquitin– proteasome system impairment, and excess amyloid beta accumulation was observed in infected mice. Interestingly, learning and memory capacity was measured using a Morris water maze, but no eect was detected. e authors con­cluded that despite the failure to link the observed abnormalities to memory impair­ment, these neurodegenerative observations may silently progress to Alzheimer’s disease if chronic cerebral toxocariasis persists.
In an important series of studies by the Strube group, all utilizing the T. c an is / T. cat i comparison, Springer et al. (2019), using both immunohistochemistry and histopathology, added weight to the ndings of Chou and colleagues but in a dif­ferent strain of mouse (Table 16.2). Beta amyloid precursor protein was enhanced in T. c ani s- infected but not in T. c at i- infected mice, and earlier and more signif­icant neurodegeneration was observed in mice infected with T. ca ni s. Waindok and Strube (2019) explored a wide range of cytokines and chemokines by means of a multiplex bead array assay (Table 16.2). In contrast to the ndings of other investigators (Eid et al., 2015; Hamilton et al., 2008; Othman et al., 2010), con­centrations of proinammatory cytokines were not elevated during To xo ca ra species infection, in contrast to those of IL- 4 and IL- 5 in T. ca ni s- infected but not in T. cat i- infected mice. Investigation of chemokines, which act as impor­tant signaling mediators, revealed that levels of proinammatory macrophage inammatory protein MIP- 1 alpha were consistently elevated in both T. ca ni s­infected and T. cat i- infected mice, as was anti- inammatory eotaxin (Waindok & Strube, 2019).
Furthermore, Waindok et al. (2019) extended their observations to the explora­tion of oxylipins— bioactive regulatory lipids that are involved in complex molecular signaling during infection and inammation (Strube et al., 2020)— to investigate lipidomic proles in the T. ca ni s- infected and T. ca ti - infected brain. Signicant in­creases in lipoxygenase pathways were observed in both infected groups indicating a predominantly anti- inammatory response.